MeSH term
Frequency | Condition_Probility | Base Sequence | 23 | 0.0 |
DNA Ligases/metabolism | 8 | 24.0 |
DNA Polymerase beta/metabolism | 3 | 23.0 |
*DNA Repair | 11 | 1.0 |
DNA-(Apurinic or Apyrimidinic Site) Lyase | 7 | 11.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Endodeoxyribonucleases/metabolism | 3 | 9.0 |
Flap Endonucleases | 19 | 63.0 |
Humans | 49 | 0.0 |
Proliferating Cell Nuclear Antigen/metabolism | 6 | 2.0 |
Research Support, Non-U.S. Gov't | 31 | 0.0 |
Binding, Competitive | 3 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Exodeoxyribonuclease V | 16 | 50.0 |
Exodeoxyribonucleases/metabolism | 3 | 23.0 |
*Flap Endonucleases | 9 | 100.0 |
Kinetics | 5 | 0.0 |
Models, Biological | 3 | 0.0 |
Molecular Sequence Data | 26 | 0.0 |
Nucleic Acid Conformation | 4 | 0.0 |
Protein Binding | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 22 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Substrate Specificity | 9 | 0.0 |
Time Factors | 2 | 0.0 |
Binding Sites | 6 | 0.0 |
DNA/*metabolism | 2 | 0.0 |
DNA Footprinting | 2 | 0.0 |
Electrophoretic Mobility Shift Assay | 2 | 0.0 |
Models, Molecular | 4 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
DNA/metabolism | 5 | 0.0 |
DNA Primers | 6 | 0.0 |
DNA Replication | 6 | 1.0 |
Hydrolysis | 3 | 0.0 |
Mutation | 5 | 0.0 |
Animals | 15 | 0.0 |
Cyclins/*metabolism | 2 | 0.0 |
DNA Damage | 5 | 0.0 |
DNA Polymerase III/metabolism | 2 | 18.0 |
DNA Repair/*physiology | 4 | 3.0 |
Deoxyribonuclease IV (Phage T4-Induced) | 5 | 10.0 |
Enzyme Activation | 3 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Proliferating Cell Nuclear Antigen/*metabolism | 4 | 2.0 |
Amino Acid Sequence | 15 | 0.0 |
Cell-Free System | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
Models, Genetic | 3 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Chromatin/metabolism | 2 | 0.0 |
Hela Cells | 4 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
DNA/genetics | 2 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Endodeoxyribonucleases/*genetics | 2 | 10.0 |
Structure-Activity Relationship | 3 | 0.0 |
Mutation/genetics | 2 | 0.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
*Chromosomes, Human, Pair 11 | 2 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
Exons | 2 | 0.0 |
Chromosomes, Human, Pair 11/*genetics | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Databases, Factual | 2 | 0.0 |
Expressed Sequence Tags | 3 | 0.0 |
Physical Chromosome Mapping | 2 | 0.0 |
RNA, Messenger/analysis/genetics | 2 | 0.0 |
Mice | 3 | 0.0 |
Transfection | 2 | 0.0 |
DNA Repair | 7 | 1.0 |
Endodeoxyribonucleases/*metabolism | 2 | 11.0 |
Oligodeoxyribonucleotides/chemistry/metabolism | 2 | 6.0 |
Protein Conformation | 2 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Templates, Genetic | 2 | 1.0 |
Cell Line | 3 | 0.0 |
Exodeoxyribonucleases/chemistry/*metabolism | 3 | 100.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Exodeoxyribonucleases/*metabolism | 2 | 14.0 |
Blotting, Western | 3 | 0.0 |
*DNA Replication | 5 | 2.0 |
S Phase | 2 | 0.0 |
Recombinant Proteins/chemistry | 2 | 0.0 |
Enzyme Inhibitors/metabolism | 2 | 0.0 |
Protein Folding | 2 | 0.0 |
Female | 2 | 0.0 |
DNA Polymerase III | 2 | 8.0 |
*Mutation | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Cattle | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Immunoprecipitation | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Endodeoxyribonucleases/*physiology | 2 | 40.0 |